Filing metadata

Accession number
0001127602-25-019413
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jul 18, 2025
Reporting period
Jul 17, 2025
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub